Products & Therapies

The Octapharma portfolio focuses on protein and other biopharmaceutical products derived from human plasma, in three therapeutic areas:

  • Haematology
    Coagulation factors to treat bleeding disorders.
  • Intensive Care and Emergency Medicine 
    Plasma and blood proteins (such as albumin) used to stabilise blood circulation, restore coagulation function, and prevent shock, e.g., for heavy burns, injuries, and in surgery.
  • Immunotherapy
    Immunoglobulins to treat immune disorders and prevent rhesus incompatibility in pregnancies.

These three areas form Octapharma’s International Business Units (IBUs), which are responsible for the Group’s overall global product strategies.

 

Each IBU works together with local sales and marketing teams, pursuing the best strategies for Octapharma products according to current market needs.

 

Headed by the International Business Unit Managers (IBMs), the IBUs are located in Lachen, Switzerland.

Strong Commitment

Octapharma’s unique focus on discovering, developing and manufacturing plasma-derived biopharmaceuticals has resulted in an accumulation of in-depth knowledge on these products and their manufacture. We are continuously seeking to improve products and find new applications.

 

The ability and willingness of our people to go from good to great, together with their long-term commitment to patients, ensures safe and effective therapies for now and in the future.